W. van den Brink
Part II focuses on DBS treatment in patients with a psychiatric disorder and specifically in patients with OCD. In chapter 4, we review the literature on the efficacy and safety of DBS in patients with a psychiatric disorder, including patients with OCD, major depressive disorder, addiction and Tourette syndrome. In chapter 5 and chapter 6 we investigate hypomania and hyperimpulsivity as possible side effects of DBS in psychiatric patients. Finally, in chapter 7, we explore the effects of NAc DBS on the frontostriatal circuitry in OCD patients using fMRI and EEG.
Part III focuses on DBS as a treatment for addiction. In chapter 8, we present a review of the existing pre-clinical and clinical literature to make an evidence-based decision about the best target area for DBS in patients with an addiction. In chapter 9, we present data about the first patient of our study treated with NAc DBS for heroin addiction. Finally in chapter 10, we describe our experiences during the recruitment of addiction patients for DBS and we raise the question whether DBS is a feasible option for patients with addiction.
In Part IV we summarize our findings, put them in the context of the existing literature and discuss their implications for future research and clinical practice.
If you believe that digital publication of certain material infringes any of your rights or (privacy) interests, please let the Library know, stating your reasons. In case of a legitimate complaint, the Library will make the material inaccessible and/or remove it from the website. Please Ask the Library, or send a letter to: Library of the University of Amsterdam, Secretariat, Singel 425, 1012 WP Amsterdam, The Netherlands. You will be contacted as soon as possible.